This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Jarmo Wahlfors: Innovator in Retroviral Packaging Technology
Introduction
Jarmo Wahlfors is a notable inventor based in Columbia, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of retroviral packaging technologies. His innovative work has implications for gene therapy and viral vector research.
Latest Patents
Wahlfors holds a patent for "Retroviral packaging cassettes amplified in the cytoplasm by autocatalytic Togavirus vectors." This invention provides a Togavirus-amplified retrovirus vector and a novel method for packaging a retrovirus cassette that contains a heterologous nucleic acid. The technology allows for amplification in a packaging cell cytoplasm by a Togavirus vector. The retroviral cassette is then packaged into infectious retrovirus particles by retroviral packaging cells. These particles are utilized to infect host cells, showcasing the potential for advanced therapeutic applications.
Career Highlights
Wahlfors is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this capacity has allowed him to contribute to important health-related innovations. His expertise in retroviral technology has positioned him as a key figure in the field.
Collaborations
Throughout his career, Wahlfors has collaborated with esteemed colleagues such as Richard A. Morgan and Kleanthis Xanthopoulos. These partnerships have fostered advancements in research and development within the biotechnology sector.
Conclusion
Jarmo Wahlfors is a distinguished inventor whose work in retroviral packaging technology has the potential to impact gene therapy significantly. His innovative patent and collaborations highlight his contributions to the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
